Wells Fargo & Company Cuts Crescent Capital BDC (NASDAQ:CCAP) Price Target to $13.00

Crescent Capital BDC (NASDAQ:CCAP) had its target price decreased by Wells Fargo & Company from $14.00 to $13.00 in a research report released on Friday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Other equities research analysts also recently issued research reports about the company. Oppenheimer decreased their price target on Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Friday, November 14th. Keefe, Bruyette & Woods reduced their target price on shares of Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a research note on Friday, November 14th. Wall Street Zen upgraded shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. Finally, Zacks Research upgraded shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.13.

Crescent Capital BDC Trading Down 4.2%

CCAP opened at $12.66 on Friday. Crescent Capital BDC has a fifty-two week low of $12.62 and a fifty-two week high of $18.57. The firm has a market capitalization of $467.41 million, a PE ratio of 13.47 and a beta of 0.57. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.22 and a quick ratio of 1.22. The company’s 50-day moving average is $14.19 and its 200 day moving average is $14.49.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.01. The business had revenue of $40.80 million during the quarter, compared to the consensus estimate of $39.83 million. Crescent Capital BDC had a return on equity of 9.32% and a net margin of 20.64%. As a group, research analysts predict that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be given a $0.42 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.68 annualized dividend and a yield of 13.3%. Crescent Capital BDC’s payout ratio is currently 178.72%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Alpine Global Management LLC raised its holdings in shares of Crescent Capital BDC by 82.6% in the 4th quarter. Alpine Global Management LLC now owns 401,756 shares of the company’s stock worth $5,645,000 after purchasing an additional 181,756 shares during the period. Invesco Ltd. grew its holdings in Crescent Capital BDC by 1,504.9% during the fourth quarter. Invesco Ltd. now owns 659,696 shares of the company’s stock valued at $9,269,000 after purchasing an additional 618,590 shares during the period. NewEdge Advisors LLC increased its position in Crescent Capital BDC by 20.2% in the fourth quarter. NewEdge Advisors LLC now owns 12,279 shares of the company’s stock worth $173,000 after buying an additional 2,066 shares during the last quarter. Almitas Capital LLC raised its stake in shares of Crescent Capital BDC by 18.0% in the fourth quarter. Almitas Capital LLC now owns 444,234 shares of the company’s stock valued at $6,241,000 after buying an additional 67,773 shares during the period. Finally, Trexquant Investment LP lifted its position in shares of Crescent Capital BDC by 145.0% during the 4th quarter. Trexquant Investment LP now owns 173,480 shares of the company’s stock valued at $2,437,000 after buying an additional 102,662 shares during the last quarter. 49.46% of the stock is owned by institutional investors.

Crescent Capital BDC News Roundup

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: Q4 results slightly beat expectations — EPS of $0.45 topped consensus by $0.01 and revenue modestly beat estimates; management highlighted strong dividend coverage in the quarter. Article: Q4 2025 Earnings Highlights
• Positive Sentiment: Board declared a quarterly dividend of $0.42 per share (annualized yield ~12.7%), with record date March 31 and payment April 15 — supports income-focused investor demand and signals current cash return commitment.
• Neutral Sentiment: Earnings call transcripts were posted (multiple outlets). These provide more detail on portfolio performance, credit quality and rate sensitivity for investors doing deeper due diligence. InsiderMonkey Transcript Seeking Alpha Transcript
• Neutral Sentiment: Reported short-interest data appears anomalous/zero in the latest report and is unlikely to be a meaningful driver (data error or reporting issue).
• Negative Sentiment: Wells Fargo cut its price target from $14 to $13 and kept an “equal weight” rating — the downgrade reduces near-term analyst support and may pressure sentiment. Article: Wells Fargo price target cut
• Negative Sentiment: Management signaled a review of the dividend and fee structure amid lower base rates — introduces uncertainty about future payout levels or fee income, which can weigh on the BDC’s valuation and income investor confidence. Article: Dividend/fee structure review

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.